Takayuki Nada
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takayuki Nada.
Investigative Radiology | 1997
Yuko Kono; Fuminqri Moriyasu; Yoshitaka Mine; Takayuki Nada; Naohisa Kamiyama; Yoshiki Suginoshita; Takeshi Matsumura; Kyoko Kobayashi; Tsutomu Chiba
RATIONALE AND OBJECTIVES The authors evaluate the efficacy of SHU 508A, a galactose-based contrast agent used in gray-scale second harmonic imaging in vitro and in vivo experiments. METHODS A Toshiba prototype harmonic imaging system (2.5/5.0 MHz) was used with SHU 508A in a phantom experiment and to image the liver in five healthy rabbits and one rabbit that had VX-2 tumors in the liver. RESULTS In the second harmonic imaging, most of the fundamental components of the backscattered echo were eliminated, and good images with high contrast were obtained in the phantom experiment. Liver parenchyma was enhanced clearly in all rabbits at 0.3 mL/kg, an effect that lasted for 90 seconds. The tumor, which was mostly necrotic, was depicted clearly as a negative enhanced area surrounded by enhanced healthy liver. CONCLUSIONS Gray-scale second harmonic imaging is a promising new method for visualization of perfusion of organs.
Ultrasound in Medicine and Biology | 1997
Yuko Kono; Fuminori Moriyasu; Takayuki Nada; Yoshiki Suginoshita; Takeshi Matsumura; Kyoko Kobayashi; Takefumi Nakamura; Tsutomu Chiba
Gray scale second harmonic imaging (2.5 MHz/5.0 MHz) was evaluated in preliminary animal studies with a new ultrasound contrast agent (FS069). FS069 was administered intravenously in 10 rabbits (6 with normal liver, and 4 with implanted VX-2 tumors) and two woodchucks with hepatocellular carcinomas. The vasculature (including tumor vessels) and liver parenchyma were clearly enhanced at a low dosage (optimal dose was from 0.1 to 0.2 mL/kg) in all cases. Enhancement was reproducible and generally dose-dependent. Tumors were enhanced well during the early phase and tumor enhancement disappeared earlier than that of surrounding normal liver. Arterial phase and portal phase were easily distinguished and patterns of enhancement were diagnostic of the tumors. Gray scale second harmonic imaging is useful in the detection of hepatic tumors and in diagnosis of their hemodynamics.
Transplantation | 1995
Masazumi Fujimoto; Fuminori Moriyasu; Takayuki Nada; Yoshiki Suginoshita; Yuko Ito; Koji Nishikawa; Hitoshi Someda; Minoru Okuma; Yukihiro Inomata; Nobuhiro Ozaki; Koichi Tanaka; Yoshio Yamaoka
We investigated the influence of spontaneous portosystemic collateral pathways on the portal hemodynamics and examined the necessity for ligating these vessels in pediatric liver transplantation from living donors. We assessed portal blood flow before, during, and after surgery in 82 pediatric recipients (mean age, 4.2 years), using Doppler ultrasonography. When blood flow in the reconstructed portal vein was decreased (< 10 ml/min/kg body weight) and portosystemic collaterals persisted during surgery, those vessels were ligated and Doppler flowmetry was examined again. Spontaneous portosystemic collaterals were detected at one or more sites in 67 patients before transplantation. These collaterals had been ligated in 17 patients before intraoperative flowmetry. Among the remaining 50 patients, initial Doppler studies revealed a decrease in portal blood flow in 22 patients. Nine patients had hepatofugal splenic venous flow and 6 had no significant flow signals from the intrahepatic portal vein. Ligation of collaterals resulted in a remarkable increase in portal blood flow in 20 patients, all of whom are alive. The remaining 2 patients died of graft failure due in part to portal hypoperfusion. On the other hand, the collaterals were not ligated in 24 patients because adequate portal blood flow was confirmed by intraoperative flowmetry. Postoperatively, flow signals from the unligated collateral vessels gradually diminished, but they still persisted in 3 patients at 12 months after transplantation. Hepatofugal blood flow through the portosystemic collateral pathways may persist after implantation of a normal graft. If the patent collaterals significantly reduce the effective portal blood flow, these vessels should be ligated in order to avoid graft failure.
Transplant International | 1995
Masazumi Fujimoto; Fuminori Moriyasu; Hitoshi Someda; Takayuki Nada; Minoru Okuma; Shinji Uemoto; Yukihiro Inomata; Koichi Tanaka; Yoshio Yamaoka; Kazue Ozawa
Percutaneous transluminal angioplasty was performed for venous stenosis after living related liver transplantation in three children. Two of them had hepatic vein stenosis and one had stenosis of both the hepatic and portal veins. Progressive development of ascites and deterioration of liver function were found in all cases. Serial Doppler ultrasound studies showed that the flow velocity in the hepatic vein gradually decreased with a flattened velocity waveform, followed by a decrease in portal blood flow. After a successful hepatic vein angioplasty, the velocity in the hepatic and portal veins increased and the Doppler waveform in the hepatic vein became pulsatile in two cases. In the remaining case, a remarkable recovery of both graft perfusion and clinical findings was achieved via combined hepatic vein and portal vein angioplasty. We conclude that balloon angioplasty is an effective alternative to surgery for post-transplant vascular stenosis and that Doppler ultrasound is useful in monitoring graft circulation.
Hepatology Research | 2007
Miho Hayashi; Kenji Ikezawa; Akiko Ono; Sachiyo Okabayashi; Yoshito Hayashi; Satoshi Shimizu; Tatsuyoshi Mizuno; Kosaku Maeda; Tomofumi Akasaka; Masafumi Naito; Tomoki Michida; Dan Ueshima; Takayuki Nada; Kiyotaka Kawaguchi; Tekefumi Nakamura; Kazuhiro Katayama
Aim: Disorders of protein metabolism in liver cirrhosis can affect prognosis or cause complications. Treatment with branched‐chain amino acid (BCAA) and zinc supplements has been shown to be effective against abnormal nitrogen metabolism in liver cirrhosis. There are, however, few studies on the effects of combining these supplements. In this study, the effect of combining BCAA and zinc treatment in cirrhosis was investigated.
Journal of Ultrasound in Medicine | 1999
Yuko Kono; Fuminori Moriyasu; Takayuki Nada; Yoshiki Suginoshita; Takeshi Matsumura; Yasunobu Toda; Takefumi Nakamura; Tsutomu Chiba
Ultrasonographic arterial portography was evaluated with second harmonic and conventional gray scale imaging after the administration of 0.001 to 0.1 ml/kg of FS069 (Optison) in 10 dogs (four dogs with ligation of the portal vein branch) and two woodchucks with hepatocellular carcinomas. Harmonic imaging was required to obtain good liver parenchymal enhancement for ultrasonographic arterial portography to be useful. The tumors were visible as regions of greater enhancement after intravenous injection and as hypoechoic regions after superior mesenteric artery injection. The segments with portal vein ligation were not detected after intravenous injection but were clearly seen after superior mesenteric artery injection. Doppler signal measurement verified a significant difference between the portal vein and hepatic vein after superior mesenteric artery injection and in the femoral artery after intravenous versus superior mesenteric artery injection, demonstrating that minimal levels of FS069 pass through the liver.
Clinical Transplantation | 1997
Fujimoto M; Fuminori Moriyasu; Takayuki Nada; Takuya Inomoto; K. Tanaka; Yoshio Yamaoka
Transplantation Proceedings | 1995
Masazumi Fujimoto; Fuminori Moriyasu; Hitoshi Someda; Takayuki Nada; Minoru Okuma; Yukihiro Inomata; Koichi Tanaka; Yoshio Yamaoka
Clinical Transplantation | 1998
Tetsuro Hirose; Takuya Inomoto; Masaaki Awane; Yoshiharu Shirakata; Takayuki Nada; Fuminori Moriyasu; Shinji Uemoto; Yukihiro Inomata; Akira Tanaka; Koichi Tanaka; Yoshio Yamaoka
Journal of Ultrasound in Medicine | 1997
Takayuki Nada; Fuminori Moriyasu; Yuko Kono; Yoshiki Suginoshita; Takeshi Matsumura; Kyoko Kobayashi; Takefumi Nakamura; Tsutomu Chiba